KCG
CASC

Knight Capital Group’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Knight Capital Group’s Portfolio CASC Stock Details CASC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2013
Q2 		$38K Buy
+4,113
New +$38K ﹤0.01% 1935